AKRO AKERO THERAPEUTICS INC

Ownership history in STRS OHIO  ·  15 quarters on record

This page tracks every 13F SEC filing in which STRS OHIO reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 14,000 0% 0.00% $665K
2025 Q2 ADDED 14,000 +1,400 +11.1% 0.00% $747K
2025 Q1 UNCHANGED 12,600 0% 0.00% $510K
2024 Q3 ADDED 12,600 +12,400 +6200.0% 0.00% $361K
2024 Q2 UNCHANGED 200 0% 0.00% $5K
2024 Q1 REDUCED 200 -1,800 -90.0% 0.00% $5K
2023 Q4 ADDED 2,000 +1,000 +100.0% 0.00% $46K
2023 Q3 ADDED 1,000 +600 +150.0% 0.00% $50K
2023 Q2 REDUCED 400 -2,200 -84.6% 0.00% $18K
2020 Q4 UNCHANGED 2,600 0% 0.00% $67K
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding AKRO

As of 2025 Q4 — sorted by position size

Nebula Research & Development LLC 0.07% IFP Advisors, Inc 3Y 7Y 0.0%
← Back to STRS OHIO Holdings